Skip to main content
. 2021 Feb 28;13(3):798. doi: 10.3390/nu13030798

Figure 4.

Figure 4

Comparison of the blood pressure variability in hypertensive patients after 30 days of supplementation with EVCO or placebo, combined or not with aerobic physical training. One-way ANCOVA of repeated measures corrected for age (n = 43). (A) SD–MAP: (Time factor (p = 0.696 and η2 0.004); group factor (p = 0.595 and η2 = 0.048); and interaction factor (p = 0.233 and η2 = 0.105). (B) ARV–MAP: (Time factor (p = 0.848 and η2 0.001); group factor (p = 0.673 and η2 = 0.039); and interaction factor (p = 0.434 and η2 = 0.069).